Novo expects to continue to grow its reach in 2025, though perhaps not at the magnitude witnessed in 2024. For the full year to come, Novo Nordisk is eyeing sales growth at constant currencies between ...

Sales of Novo Nordisk’s obesity drug, Wegovy, rose by more than 50 per cent last year, helping the Danish drugmaker beat revenue expectations.

A new study from EMBL Barcelona researchers shows that metabolic activities selectively modulate the segmentation clock, ...

After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year ...

Stargardt disease type 1 (STGD1) is an inherited retinal recessive disease caused by biallelic variants in the ABCA4 gene. One of the recurrent variants is located at the exon-intron junction of exon ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

Emerging markets are becoming AI innovation hubs driven by unique challenges, diverse datasets, and evolving technology ...

Africans and black people from allover Africa and the world over are being urged to wake up from centuries old slumber and realize that now is the time to unite as one and work for the actualization ...

Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...

Good morning and good afternoon, and welcome to the Novartis Q4 2024 results release conference call and live webcast.

A ribozyme is a ribonucleic acid (RNA) molecule with the ability to catalyze a biochemical reaction a function more commonly carried out by proteins. It is generally believed that ribozymes ...